Online Activities

The Lipid Panel

The Lipid Panel is a monthly series hosted live on the last Tuesday of each month at 8PM Eastern Time. The webcast series features unique case discussions on a variety of topics in the field of lipidology, presented and discussed by a panel of expert faculty.

National Lipid Association
Journal Club

The NLA Journal Club is a series of free webinars designed to keep lipidologists up-to-date on the newest topics and techniques in Clinical Lipidology. Each webinar will include a short presentation and focused discussion from one of our senior members on the chosen journal/publication.

NLA Self Assessment Program

The NLA-SAP series is a comprehensive, interactive clinical problem-solving program that validates, strengthens and reinforces your knowledge of the core curriculum of clinical lipidology. The program provides a critical assessment of your strengths and weaknesses to guide you in the selection of additional CME training courses.

Lipid Education Online

Lipid Education Online is a user-friendly, tech-savvy adaptation of the NLA's live training courses. The National Lipid Association's outstanding live courses are reproduced here in a self-paced, mobile-friendly and interactive online learning experience, especially designed to give you all the tools you need to pursue lipidology as a full-fledged lipid specialist or to enhance your existing practice of medicine.

Past Meeting Highlights

The NLA takes pride in our speakers, so much so that we've built up a library of clinical lipidology talks, presentations, and case studies from past years. A great benefit of being an NLA member is that you have the ability to watch talks and presentations from our past conferences online.

Lipid Insights

Tune in quarterly and hear from Dr. Alan Brown as he talks with expert speakers to gain insights on some of the leading topics in the field of lipidology.

Prioritizing Lp(a) Screening and LDL-C Lowering to Transform Cardiovascular Risk Across the ASCVD Continuum

Managing cardiovascular risk requires addressing more than just LDL-C. Elevated lipoprotein(a), or Lp(a), is now recognized as a genetically determined, independent risk enhancer for ASCVD.

This two-part CME series features Erin D. Michos, MD, MHS and Pamela B. Morris, MD FACC, FAHA, FASPC, FNLA, who provide practical guidance on identifying, assessing, and managing patients with elevated LDL-C and Lp(a).

Beyond Statins: Evolving Therapeutic Options for Dyslipidemia Management

Beyond Statins: Evolving Therapeutic Options for Dyslipidemia Management aims to provide healthcare professionals with a comprehensive understanding of the mechanisms of action of various non-statin therapies for managing different types of dyslipidemias. Participants will enhance their ability to apply evidence-based decision making in selecting appropriate therapies tailored to individual patient needs, evaluate the integration of emerging therapies into clinical practice and discuss strategies to improve the overall knowledge and performance of the healthcare team.

Early, Sustained, and Comprehensive Control of Lipids and Health: From Therapies to Models of Care

The National Lipid Association and European Atherosclerosis Society partnered to offer a two-part symposium series to provide an in-depth exploration of lipid-modifying therapies, targeting various lipid components and considering holistic models of care for effective lipid management. Attendees will gain insights from leading experts on LDL-C reduction, the role of remnant cholesterol and triglyceride-rich lipoproteins, the latest advances in the role of Lp(a) in both risk assessment and treatment, and systems approaches to improving lipid management.

Reexamining CETP Inhibition to Reduce CVD in High-risk Populations: A Focus on LDL-C Reduction

Posted July 12, 2024

Join an expert panel of cardiologists to review emerging data on CETP inhibition for LDL-C lowering in this 60-minute CME-accredited HCP activity. Experts will discuss current guidelines and best practices for lipid management, limitations of current practice in reaching LDL-C goals, and clinical trial findings on an investigational CETP inhibitor with improved selectivity, potency, efficacy, and safety compared with agents in this class previously in development.

From a to B, then Back to LDL: Transatlantic Views on the Lipoproteins that Cause Plaque

Posted July 11, 2024

The National Lipid Associations outstanding joint session with the European Atherosclerosis Society originally presented at the NLA's 2024 Scientific Sessions in Las Vegas, NV

LipidPalooza 2022

Posted September 29, 2022

We are excited to have offered a virtual educational series featuring multiple episodes in combination with NLA leadership and our industry partners. This virtual series celebrating National Cholesterol Education Month is now available and offered at no charge for all. Experts in the field of Lipidology cover content on specific topic in the field, some presentations also contain a presentation by one of our industry partner with relevant clinical trial(s) information in that area.